Skip to main content
logo
Veradermics, Incorporated (MANE)
NYSE: MANE · Real-Time Price · USD
102.82
-2.50 (-2.37%)
Aug 21, 2026, 4:00 PM EDT - Market closed

Veradermics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Cash & Equivalents
319.3321.7753.0816.3
Short-Term Investments
500.56120.1--
Cash & Short-Term Investments
819.89141.8653.0816.3
Cash Growth
-167.24%225.75%-
Other Receivables
1.591.261.38-
Receivables
1.591.261.38-
Prepaid Expenses
2.135.611.041.22
Other Current Assets
1.143.770.040.05
Total Current Assets
824.75152.4955.5417.56
Property, Plant & Equipment
0.990.13--
Total Assets
825.74152.6255.5417.56

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Accounts Payable
5.922.132.251.85
Accrued Expenses
5.46.982.471.2
Other Current Liabilities
0.380.05--
Total Current Liabilities
11.699.154.723.05
Long-Term Debt
---0.79
Long-Term Leases
0.430--
Total Liabilities
12.129.164.723.84

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Common Stock
0000
Additional Paid-In Capital
989.262.350.750.5
Retained Earnings
-174.16-123.42-49.23-22.74
Comprehensive Income & Other
-1.49-1.79-3.85-0.89
Total Common Equity
813.61-122.86-52.33-23.14
Shareholders' Equity
813.61143.4650.8213.72
Total Liabilities & Equity
825.74152.6255.5417.56

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Total Debt
0.430-0.79
Net Cash (Debt)
819.47141.8653.0815.51
Net Cash Growth
-167.23%242.26%-
Net Cash Per Share
50.63190.4272.0321.05
Filing Date Shares Outstanding
41.7837.340.740.74
Total Common Shares Outstanding
41.780.750.740.74
Working Capital
813.05143.3450.8214.51
Book Value Per Share
19.47-163.87-71.01-31.39
Tangible Book Value
813.61-122.86-52.33-23.14
Tangible Book Value Per Share
19.47-163.87-71.01-31.39
SEC Filings: 10-K · 10-Q